Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis

ConclusionBased on our findings, this study may support the efficacy and safety of switching from OAPs to PP1M for the treatment of patients with schizophrenia. Future large-scale studies are warranted to confirm our findings.

http://link.springer.com/10.1007/s40263-023-01028-1

Source: CNS Drugs - July 25, 2023 Category: Neurology Source Type: research